‘Queremos tener las cosas ocultas pero pienso que también somos guerreras': Non-disclosure and Secrecy among Latina Breast Cancer Survivors
Methods: Drawing from in-depth, semi-structured interviews (n=95) gathered during two studies with LBCS in west central Florida, this presentation analyzed the emerging theme of non-disclosure and secrecy through axial coding, focusing on how it impacted coping strategies, sources of support, and help-seeking behavior. Participants were within 5 years of initial breast cancer diagnosis and had completed primary treatment.
Results: Resistance to disclosure was linked with a variety of motivators, including desires to avoid burdening family and fears of stigma. These hesitations functioned as impediments to seeking formal mental health services and informal support from family and friends, further compounding women’s distress. However, among some women, disclosure led to positive outcomes such as catharsis.
Conclusion: Determinants of distress are multifaceted, and LBCS’s hesitations towards disclosure appear to be rooted in cultural beliefs of privacy and social risks of disclosing. Findings suggest that interventions seeking to reduce the perceived cost of disclosure while leveraging its benefits may improve help-seeking behaviors, contributing to improved survivorship and quality of life.
Learning Areas:Diversity and culture
Social and behavioral sciences
Discuss Latina breast cancer survivors’ motivations for and experiences with non-disclosure of diagnosis and mental health issues Examine how non-disclosure impacts Latina breast cancer survivors’ coping strategies, sources of support, and help-seeking behavior
Qualified on the content I am responsible for because: I am the PI of this study. I was responsible for the conceptualization of the project, design, implementation, and analysis of the project. My background and experience are extensive in the area of Latina breast cancer survivorship.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.